Archive: 10/10/2016
Copay assistance is the problem, not the solution to high drug prices
Copay assistance is part of the drug pricing problem, not a solution to it, according to several health policy experts in a commentary published in Annals of Internal Medicine. The experts offer five reasons why programs ...
Oct 10, 2016
The need to replace EpiPens regularly adds to concerns about cost
As controversy about the pricing of EpiPens reverberates from Capitol Hill to school districts across the country, one recurring complaint from consumers is that the high cost is magnified because the drug expires quickly, ...
Oct 10, 2016